Yongsheng Wang

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 10

Top Topics

Bioinformatics Analysis

Tyrosine Kinase

Top Venues

Molecular biomedicine

Thoracic cancer

Precision clinical medicine

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yanna Lei, Shasha Zeng, Xiaoyu Li, Pei Shu, Weiya Wang, Yongsheng Wang
Partial treatment response to alectinib in metastatic non-small cell lung cancer with KIDINS220-ALK fusion. Precision clinical medicine 6 (2) (2023)
Tao Jiang, Qiqi Jin, Jiahao Wang, Feng-Ying Wu, Jian Chen, Gongyan Chen, Yunchao Huang, Jianhua Chen, Ying Cheng, Qi-Ming Wang, Yue-Yin Pan, Jian-Ying Zhou, Jianhua Shi, Xingxiang Xu, LiZhu Lin, Wei Zhang, Yiping Zhang, Yun-Peng Liu, Yong Fang, Jifeng Feng, Zhehai Wang, Sheng Hu, Jian Fang, Yongqian Shu, Jiu-Wei Cui, Yi Hu, Wenxiu Yao, Xingya Li, Xiaoyan Lin, Rui Wang, Yongsheng Wang, Wei Shi, Gaohua Feng, Jun Ni, Beibei Mao, Dandan Ren, Huaibo Sun, Henghui Zhang, Luo-Nan Chen, Cai-Cun Zhou, Shengxiang Ren
HLA-I evolutionary divergence confers response to PD-1 blockade plus chemotherapy in untreated advanced non-small-cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ge Gao, Weiting Liao, Pei Shu, Qizhi Ma, Xia He, Benxia Zhang, Diyuan Qin, Yongsheng Wang
Targeting sphingosine 1-phosphate receptor 3 inhibits T-cell exhaustion and regulates recruitment of proinflammatory macrophages to improve antitumor efficacy of CAR-T cells against solid tumor. Journal for immunotherapy of cancer 11 (8) (2023)
Zixi Wang, Yurou Xing, Bingjie Li, Xiaoyu Li, Bin Liu, Yongsheng Wang
Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer. Molecular biomedicine 3 (1) (2022)
Benxia Zhang, Xue Li, Tao Yin, Diyuan Qin, Yue Chen, Qizhi Ma, Pei Shu, Yongsheng Wang
Neurotoxicity of Tumor Immunotherapy: The Emergence of Clinical Attention. Journal of oncology 2022 (2022)
Zixi Wang, Yurou Xing, Bingjie Li, Xiaoyu Li, Bin Liu, Yongsheng Wang
Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer. Molecular biomedicine 3 (1) (2022)
Zixi Wang, Yurou Xing, Bingjie Li, Xiaoyu Li, Bin Liu, Yongsheng Wang
Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer. Molecular biomedicine 3 (1) (2022)
Dan Li, Fuchun Guo, Ke Chen, Xunning Yang, Yongsheng Wang
Preclinical Safety Evaluation of a Recombinant Plasmid Vector Encoding Mature Human Neutrophil Peptide-1 by Repeated Local Administrations in Nonhuman Primates. Human gene therapy 32 (21-22) (2021)
Xueqian Wu, Weiya Wang, Bingwen Zou, Yanying Li, Xiaojuan Yang, Ning Liu, Qizhi Ma, Xiaoxuan Zhang, Yongsheng Wang, Yong-Sheng Wang
Novel NLRC4-ALK and EML4-ALK double fusion mutations in a lung adenocarcinoma patient: A case report. Thoracic cancer 11 (6) (2020)
Xiaoxuan Zhang, Li Wu, Yong Xu, Benxia Zhang, Xueqian Wu, Yongsheng Wang, Zongguo Pang
Trends in the incidence rate of lung cancer by histological type and gender in Sichuan, China, 1995-2015: A single-center retrospective study. Thoracic cancer 9 (5) (2018)